Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Deciding between cash back and rewards cards depends on your spending habits. Analyze your needs to find the best option for you.
26,062 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Investors can buy stakes in the first Atari Hotel Phoenix via a Regulation A+ offering, marking a bold move by the ic...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bond markets show renewed stress, with yields rising and liquidity thinning. Analysts say a familiar pattern is reeme...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Goldman Sachs argues that a rapid, AI-driven reordering of jobs remains unlikely. There’s little evidence of a broad ...
A young professional beats the odds after a wrist injury derailed college plans, turning setback into a leadership jo...
A modern LA private retreat tied to the ‘entourage’ star jeremy piven has sold for $6.9 million after months on the m...
As of mid-2026, the U.S. housing market remains tight. Boomers hold many homes and aren’t selling fast, while Millenn...
Pump.fun’s PUMP token faces a major insider unlock totaling $127 million. If insiders hold, liquidity may hold; if th...
Google is pursuing a hardware-first approach to running Gemini's AI stack. This article breaks down what a dedicated ...
Rechat teams with Canva to streamline listing marketing, letting listing data flow into Canva and back with one click...